Feb 9 (Reuters)-
SymBio Pharmaceuticals Limited
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Dec 31, 2015 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.37 1.93 2.90
(+22.5 pct) (-1.1 pct) (+22.6 pct)
Operating loss 2.13 loss 2.55 loss 3.24
Recurring loss 2.32 loss 2.63 loss 3.30
Net loss 2.31 loss 2.63 loss 3.31
EPS loss 58.82 yen loss 81.26 yen loss 71.07 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - SymBio Pharmaceuticals Limited.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T
((Tokyo Headline News Desk +813 6441 1812))